As on :
05-Aug-26 20:57
Amanta Healthcare Limited (BSE: 544502, NSE: AMANTA) announced its unaudited financial results for the quarter ended June 30, 2026, reporting revenue of Rs 68.8 crore, a 5.4% year-over-year increase, driven by improved product mix and better price realizations, while profit after tax declined to Rs 3.3 crore from Rs 3.5 crore in the prior year due to higher finance costs. The company's EBITDA stood at Rs 15.2 crore, with margins moderating to 22% from 24% a year ago, and plans to commission the Steriport plant in the second quarter of fiscal year 2027 and the SVP expansion in the fourth quarter of fiscal year 2027 are expected to enhance manufacturing capacity and cost efficiency.
